Digitalni repozitorij raziskovalnih organizacij Slovenije

Izpis gradiva
A+ | A- | Pomoč | SLO | ENG

Naslov:Red blood cell transfusion in European neonatal intensive care units, 2022 to 2023
Avtorji:ID Houben, Nina A. M. (Avtor)
ID Fustalo-Gunnik, Suzanne (Avtor)
ID Fijnvandraat, Karin (Avtor)
ID Caram-Deelder, Camila (Avtor)
ID Aguar Carrascosa, Marta (Avtor)
ID Beuchée, Alain (Avtor)
ID Brække, Kristin (Avtor)
ID Cardona, Francesco Stefano (Avtor)
ID Debeer, Anne (Avtor)
ID Domingues, Sara (Avtor)
ID Lozar Krivec, Jana (Avtor), et al.
Datoteke:.pdf PDF - Predstavitvena datoteka, prenos (1,09 MB)
MD5: 18116E29C542D4670B970DEC03C72DFC
 
URL URL - Izvorni URL, za dostop obiščite https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2823754
 
Jezik:Angleški jezik
Tipologija:1.01 - Izvirni znanstveni članek
Organizacija:Logo UKC LJ - Univerzitetni klinični center Ljubljana
Povzetek:Importance: Red blood cell (RBC) transfusions are frequently administered to preterm infants born before 32 weeks of gestation in the neonatal intensive care unit (NICU). Two randomized clinical trials (Effects of Transfusion Thresholds on Neurocognitive Outcomes of Extremely Low-Birth-Weight Infants [ETTNO] and Transfusion of Prematures [TOP]) found that liberal RBC transfusion thresholds are nonsuperior to restrictive thresholds, but the extent to which these results have been integrated into clinical practice since publication in 2020 is unknown. Objective: To describe neonatal RBC transfusion practice in Europe. Design, setting, and participants: This international prospective observational cohort study collected data between September 1, 2022, and August 31, 2023, with a 6-week observation period per center, from 64 NICUs in 22 European countries. Participants included 1143 preterm infants born before 32 weeks of gestation. Exposure: Admission to the NICU. Main outcomes and measures: Study outcome measures included RBC transfusion prevalence rates, cumulative incidence, indications, pretransfusion hemoglobin (Hb) levels, volumes, and transfusion rates, Hb increment, and adverse effects of RBC transfusion. Results: A total of 1143 preterm infants were included (641 male [56.1%]; median gestational age at birth, 28 weeks plus 2 days [IQR, 26 weeks plus 2 days to 30 weeks plus 2 days]; median birth weight, 1030 [IQR, 780-1350] g), of whom 396 received 1 or more RBC transfusions, totaling 903 transfusions. Overall RBC transfusion prevalence rate during postnatal days 1 to 28 was 3.4 transfusion days per 100 admission days, with considerable variation across countries, only partly explained by patient mix. By day 28, 36.5% (95% CI, 31.6%-41.5%) of infants had received at least 1 transfusion. Most transfusions were given based on a defined Hb threshold (748 [82.8%]). Hemoglobin levels before transfusions indicated for threshold were below the restrictive thresholds set by ETTNO in 324 of 729 transfusions (44.4%) and TOP in 265 of 729 (36.4%). Conversely, they were between restrictive and liberal thresholds in 352 (48.3%) and 409 (56.1%) transfusions, respectively, and above liberal thresholds in 53 (7.3%) and 55 (7.5%) transfusions, respectively. Most transfusions given based on threshold had volumes of 15 mL/kg (470 of 738 [63.7%]) and were administered over 3 hours (400 of 738 [54.2%]), but there was substantial variation in dose and duration. Conclusions and relevance: In this cohort study of very preterm infants, most transfusions indicated for threshold were given for pretransfusion Hb levels above restrictive transfusion thresholds evaluated in recent trials. These results underline the need to optimize practices and for implementation research to support uptake of evidence
Ključne besede:red blood cell transfusion, neonatal intensive care
Status publikacije:Objavljeno
Verzija publikacije:Objavljena publikacija
Leto izida:2024
Št. strani:str. 1-13
Številčenje:Vol. 7, iss. 9
PID:20.500.12556/DiRROS-29998 Novo okno
UDK:61
ISSN pri članku:2574-3805
DOI:10.1001/jamanetworkopen.2024.34077 Novo okno
COBISS.SI-ID:213511939 Novo okno
Opomba:Nasl. z nasl. zaslona; Opis vira z dne 3. 11. 2024;
Datum objave v DiRROS:11.06.2026
Število ogledov:60
Število prenosov:52
Metapodatki:XML DC-XML DC-RDF
:
Kopiraj citat
  
Objavi na:Bookmark and Share


Postavite miškin kazalec na naslov za izpis povzetka. Klik na naslov izpiše podrobnosti ali sproži prenos.

Gradivo je del revije

Naslov:JAMA network open
Skrajšan naslov:JAMA netw. open
Založnik:American Medical Association
ISSN:2574-3805
COBISS.SI-ID:6301868 Novo okno

Licence

Licenca:CC BY 4.0, Creative Commons Priznanje avtorstva 4.0 Mednarodna
Povezava:http://creativecommons.org/licenses/by/4.0/deed.sl
Opis:To je standardna licenca Creative Commons, ki daje uporabnikom največ možnosti za nadaljnjo uporabo dela, pri čemer morajo navesti avtorja.

Nazaj